Ernst Habicht is a notable inventor based in Oberwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on novel compounds with therapeutic applications. With a total of 10 patents to his name, Habicht's inventions have the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents, Habicht has developed benzodioxole derivatives that exhibit diuretic and uricosuric activity. These compounds are designed for the treatment of conditions such as oedema and hypertension. Another significant invention includes dioxaheterocyclic compounds, which also demonstrate diuretic and uricosuric properties, making them suitable for similar therapeutic applications. Both inventions highlight his focus on creating pharmaceutical compositions that can benefit mammalian health.

Career Highlights

Ernst Habicht has had a distinguished career at Ciba-Geigy Corporation, where he has been instrumental in advancing pharmaceutical research. His work has led to the development of innovative compounds that address critical health issues. His expertise in the field has positioned him as a key figure in pharmaceutical innovation.

Collaborations

Throughout his career, Habicht has collaborated with esteemed colleagues such as Pier G Ferrini and Alfred Sallmann. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Ernst Habicht's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the field and offers promising avenues for future research and development.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]